China Biologic Produ
(CBPO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 51,992 | 18,824 | 15,290 | 8,179 | 3,817 |
| Depreciation Amortization | 9,023 | 6,416 | 1,149 | 869 | 447 |
| Income taxes - deferred | -1,101 | -1,553 | N/A | N/A | N/A |
| Accounts receivable | -7,821 | -1,510 | 82 | 3,351 | -1,484 |
| Accounts payable and accrued liabilities | 505 | -59 | -377 | 94 | 1,503 |
| Other Working Capital | -26,170 | -2,289 | 1,310 | 1,144 | -2,496 |
| Other Operating Activity | 12,358 | 30,472 | 2,566 | -987 | 1,308 |
| Operating Cash Flow | $38,787 | $50,301 | $20,020 | $12,651 | $3,095 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10,313 | -3,486 | -3,960 | -7,704 | -2,649 |
| Net Acquisitions | -4,063 | 1,573 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -3,225 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -1,475 | -2,106 | -83 | -234 | -263 |
| Other Investing Activity | -1,475 | -1,722 | -17,707 | -1,507 | -869 |
| Investing Cash Flow | $-15,852 | $-6,861 | $-21,667 | $-9,211 | $-3,517 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 5,918 | 22,504 | 29 | 1,317 | 2,511 |
| Debt Issued | N/A | N/A | 5,766 | N/A | N/A |
| Debt Repayment | N/A | -2,841 | N/A | -658 | -2,531 |
| Common Stock Issued | 1,330 | 4,000 | N/A | N/A | 3,752 |
| Dividend Paid | -10,446 | -2,969 | N/A | -489 | N/A |
| Other Financing Activity | -11,080 | -19,128 | -1,009 | -3,292 | 319 |
| Financing Cash Flow | $-14,279 | $1,565 | $4,786 | $-3,122 | $4,052 |
| Exchange Rate Effect | 2,441 | 24 | 665 | 424 | 32 |
| Beginning Cash Position | 53,844 | 8,815 | 5,010 | 4,268 | 607 |
| End Cash Position | 64,941 | 53,844 | 8,815 | 5,010 | 4,268 |
| Net Cash Flow | $11,097 | $45,029 | $3,805 | $742 | $3,661 |
| Free Cash Flow | |||||
| Operating Cash Flow | 38,787 | 50,301 | 20,020 | 12,651 | 3,095 |
| Capital Expenditure | -10,313 | -3,523 | -4,034 | -7,715 | -2,649 |
| Free Cash Flow | 28,474 | 46,778 | 15,986 | 4,936 | 446 |